Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma?

被引：2
|
作者：
Burroughs, Andrew
Samonakis, Dirnitrios
机构：
[1] Royal Free Hosp, Liver Transplantat Hepatobiliary Unit, London NW3 2QG, England
[2] Univ London, London WC1E 7HU, England
[3] Royal Free Hosp, Liver Unit, London NW3 2QG, England
来源：
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2004年 / 1卷 / 02期
关键词：
percutaneous acetic acid injection; primary treatment modality; survival; transarterial chemoembolization; unresectable hepatocellular carcinoma;
D O I：
10.1038/ncpgasthep0038
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [21] Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Megan E. McNally
    Antonio Martinez
    Hooman Khabiri
    Gregory Guy
    Anthony J. Michaels
    James Hanje
    Robert Kirkpatrick
    Mark Bloomston
    Carl R. Schmidt
    Annals of Surgical Oncology, 2013, 20 : 923 - 928
  • [22] Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Zhao, Chang
    Fan, Liwei
    Qi, Feng
    Ou, Shengqiu
    Yu, Lei
    Yi, Xiaoyu
    Ni, Bingqiang
    Zheng, Zhiyong
    Lu, Jianxun
    Zhang, Chengwen
    Cheng, Changsheng
    Lu, Xiong
    Cheng, Lin
    Hu, Tianlian
    Ma, Yilong
    ANTI-CANCER DRUGS, 2016, 27 (07) : 689 - 694
  • [23] Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    McNally, Megan E.
    Martinez, Antonio
    Khabiri, Hooman
    Guy, Gregory
    Michaels, Anthony J.
    Hanje, James
    Kirkpatrick, Robert
    Bloomston, Mark
    Schmidt, Carl R.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (03) : 923 - 928
  • [24] Transarterial chemoembolization in patients with unresectable diffuse vs. focal hepatocellular carcinoma.
    Pan, SH
    Ramirez, C
    Hoffman, A
    Linda, S
    Rojter, S
    Lopez, RR
    HEPATOLOGY, 1999, 30 (04) : 683A - 683A
  • [25] Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma
    Kong, Jie-Yu
    MEDICINE, 2018, 97 (33)
  • [26] Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma
    Kim, Hyung-Don
    An, Jihyun
    Kim, Jin Hyoung
    Gwon, Dong Il
    Shin, Ji Hoon
    Ko, Gi-Young
    Yoon, Hyun-Ki
    Sung, Kyu-Bo
    Kim, Kang Mo
    Lee, Han Chu
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 27 (04) : 504 - 513
  • [27] Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis
    Georgiades, CS
    Hong, K
    D'Angelo, M
    Geschwind, JFH
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (12) : 1653 - 1659
  • [28] Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma - Comment
    Talamonti, MS
    O'Connell, TX
    Vauthey, JN
    Lopez
    ARCHIVES OF SURGERY, 2002, 137 (06) : 657 - 658
  • [29] Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma
    Wan, Xuying
    Zhai, Xiaofeng
    Yan, Zhenlin
    Yang, Pinghua
    Li, Jun
    Wu, Dong
    Wang, Kui
    Xia, Yong
    Shen, Feng
    ONCOTARGET, 2016, 7 (50) : 83806 - 83816
  • [30] Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization
    Chok, Kenneth S.
    Ng, Kelvin K.
    Poon, Ronnie T. P.
    Lam, Chi Ming
    Yuen, Jimmy
    Tso, Wai Kuen
    Fan, Sheung Tat
    ARCHIVES OF SURGERY, 2006, 141 (12) : 1231 - 1236
12345